RE:Aphria (APHA) Stock: Climbing On QuickStrip NewsHere's a cut and paste from the firm litigating Rapid Dose that might dampen enthusiasm:
HAMILTON, Ontario, Feb. 21, 2018 (GLOBE NEWSWIRE) — CTT Pharmaceutical Holdings, Inc., (OTC:CTTH), an innovative life sciences company with an extensive portfolio of IP in novel drug delivery systems, is pleased to announce that the Canadian Intellectual Property Office has granted Canadian Patent # 2,922,959, titled, “Orally Administrable Composition”, to the Company. This patent has extremely broad protection for products such as Oral Thin Films, Wafers, Strips, Tablets, Gums etc. that deliver active nanonized pharmaceuticals including Cannabinoids, Opioids and most other large therapeutic molecules. This newly issued patent expands the Company’s patent portfolio to five issued (three Canadian and two U.S.) with one U.S. patent pending and two Worldwide PCT. “This newly issued patent is the most valuable and difficult to obtain relative to the other four patents that the Company has been previously issued,” said Dr. Pankaj Modi, CEO of CTTH. “The claims allowed are so broad that virtually any entity in Canada that comes to market with a strip, wafer, tablet, or gum that has any active therapeutic molecule such as cannabinoids or opioids will be infringing upon our patent.